se of Vidangadi Loha as compared to Metformin in Prediabetes
- Conditions
- Health Condition 1: R739- Hyperglycemia, unspecified
- Registration Number
- CTRI/2021/10/037124
- Lead Sponsor
- Self Dr Sonal Abhijeet Shah
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Newly diagnosed cases of hyperglycaemia with lakshanas of Prameha like Prabhut mootrata, Trishna, Kshudhadhikya, Dourbalya, Dantadinammaladhyatvam, Atinidra with Madhumeha Assessment Tool (As mentioned in case paper) Score more than 10 and patients those having Blood Sugar level fasting 100 to 125, Postprandial Blood sugar level more than 140 and less than 200 and HbA1C 5.7 to 6.4 % will be selected for the study.{According to Rashtriya Madhumeha Abhiyan , Ministry of Ayush, Government of India} According to American Diabetes Association Criteria.
i)Type 2 Diabetes Patients, Juvenile Diabetes, Pregnancy induced Diabetes Mellitus patients will be excluded from study.
ii)Patients receiving insulin and those with increased blood sugar level and showing normal or poor control in glycosylated hemoglobin.
iii)Patients Suffering from Diabetic Complications like Neuropathy, Retinopathy, Nephropathy, keto acidosis, Gangrene will be excluded from study.
iv)Immune deficiency patient, chronic major illness will be also excluded from study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.To evaluate the efficacy of Vidgandi Loha in the management of Prediabetes based on serum levels of fasting and postprandial blood glucoseTimepoint: 90 days with Follow Up on 30th,60th and 90th day
- Secondary Outcome Measures
Name Time Method 1.To study the efficacy of Vidangadi loha in the management of Prediabetes based on serum levels of fasting and postprandial blood glucose. <br/ ><br>2.To compare the effect of Vidangadi Loha with standard Metformin in the management of Prameha with special reference to Prediabetes. <br/ ><br>3.To evaluate the efficacy of Vidangadi loha tablets in the management of Prediabetes compared with Metformin tablet based on Glycosylated hemoglobin, lipid profile and clinical symptoms. <br/ ><br>4.To review the modern literature on Prediabetes in detail. <br/ ><br>Timepoint: 90 days with Follow Up on 30th,60th and 90th day